Page last updated: 2024-11-06

ipsdienol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

ipsdienol: isolated from Ips pini [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID92301
SCHEMBL ID435578
MeSH IDM0504633

Synonyms (21)

Synonym
s-ipsdienol
2-methyl-6-methylene-2,7-octadien-4s-ol
LMPR0102010027
(4s)-(+)-ipsdienol
ipsdienol
(s)-2-methyl-6-methylene-2,7-octadien-4-ol
(4s)-2-methyl-6-methylideneocta-2,7-dien-4-ol
AKOS006272671
35628-00-3
2,7-octadien-4-ol, 2-methyl-6-methylene-, (4s)-
i0ck35047x ,
unii-i0ck35047x
(4s)-2-methyl-6-methylene-2,7-octadien-4-ol
(s)-2-methyl-6-methyleneocta-2,7-dien-4-ol
SCHEMBL435578
(s)-(+)-ipsdienol
(s)-ipsdienol
(+)-ipsdienol
DTXSID50885627
2-thiazolecarboxylicacid,4-(1-methylethyl)-(9ci)
Q13422964
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
ipsdienol biosynthesis39

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (38.10)29.6817
2010's11 (52.38)24.3611
2020's2 (9.52)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (95.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]